Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Rating) was the target of a large drop in short interest in the month of December. As of December 30th, there was short interest totalling 1,400 shares, a drop of 26.3% from the December 15th total of 1,900 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is currently 0.2 days.
Algernon Pharmaceuticals Price Performance
Shares of OTCMKTS AGNPF opened at $1.64 on Thursday. Algernon Pharmaceuticals has a 1 year low of $1.52 and a 1 year high of $9.28. The stock's 50-day simple moving average is $1.90 and its 200-day simple moving average is $2.63.
Get Algernon Pharmaceuticals alerts:Algernon Pharmaceuticals Company Profile
(Get Rating)
Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand.Featured Stories
- Get a free copy of the StockNews.com research report on Algernon Pharmaceuticals (AGNPF)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.